Other OTC redness relievers
(α1 or α1/α2-AR agonist)
Commonly associated with
rebound redness and tachyphylaxis
Non-selective vasoconstrictors
act on the arteriole, decreasing
blood and oxygen flow to
surrounding tissue.
LUMIFY with low dose brimonidine tartrate
(Selective α2-AR agonist)
No tachyphylaxis and virtually
no rebound redness in clinical trials
when used as directed
LUMIFY selectively constricts
the venule, alleviating the potential
decrease of blood and oxygen flow
to surrounding tissue.